Genetics of IL-13 and functional relevance of IL-13 variants

Studies in both humans and mice clearly show that interleukin (IL)-13 is a central regulator of allergic inflammation. Numerous single nucleotide polymorphisms have been recently identified in the IL-13 gene and have been found to be associated with allergic and/or asthmatic phenotypes in different populations throughout the world. Furthermore, functional genomics studies are highlighting mechanistic pathways that may link genetic variation in IL-13 and disease. IL-13 is therefore an ideal model to study the impact of genetic variation on the regulation of gene expression and function in complex diseases.

[1]  Susan J Wilson,et al.  Cooperative Effects of Th2 Cytokines and Allergen on Normal and Asthmatic Bronchial Epithelial Cells1 , 2002, The Journal of Immunology.

[2]  R. Puri,et al.  Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. , 2002, The Journal of allergy and clinical immunology.

[3]  D. Corry,et al.  The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. , 2002, American journal of respiratory cell and molecular biology.

[4]  M. Kabesch,et al.  The single nucleotide polymorphism −1112C→T attenuates IL-13 transcription and creates an Oct-1 binding site that interferes with STAT-1 dependent promoter activation , 2002 .

[5]  D. Postma,et al.  Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. , 2002, American journal of human genetics.

[6]  D. Vercelli.  The functional genomics of CD14 and its role in IgE responses: an integrated view. , 2002, The Journal of allergy and clinical immunology.

[7]  C. Karp,et al.  A Common Single Nucleotide Polymorphism in the CD14 Promoter Decreases the Affinity of Sp Protein Binding and Enhances Transcriptional Activity1 , 2001, The Journal of Immunology.

[8]  N. Kaminski,et al.  Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. , 2001, American journal of respiratory cell and molecular biology.

[9]  D. Postma,et al.  Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. , 2001, American journal of respiratory cell and molecular biology.

[10]  J. Koziol,et al.  Characterization of Inherited Differences in Transcription of the Human Integrin α2 Gene* , 2001, The Journal of Biological Chemistry.

[11]  R. Powers,et al.  Solution structure of human IL-13 and implication for receptor binding. , 2001, Journal of molecular biology.

[12]  D. Vercelli.  Immunoglobulin E and its regulators , 2001, Current opinion in allergy and clinical immunology.

[13]  B. Ma,et al.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. , 2000, The Journal of clinical investigation.

[14]  R S Judson,et al.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  U. Wahn,et al.  An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). , 2000, The Journal of allergy and clinical immunology.

[16]  R. Puri,et al.  Conversion of Interleukin-13 into a High Affinity Agonist by a Single Amino Acid Substitution* , 2000, The Journal of Biological Chemistry.

[17]  J. Warner,et al.  Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. , 2000, The Journal of allergy and clinical immunology.

[18]  S. Weiland,et al.  A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. , 2000, The Journal of allergy and clinical immunology.

[19]  K. Deichmann,et al.  Genetic variants of IL-13 signalling and human asthma and atopy. , 2000, Human molecular genetics.

[20]  K. Deichmann,et al.  Atopy and asthma: genetic variants of IL-4 and IL-13 signalling , 2000 .

[21]  U. Wahn,et al.  Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES1 , 2000, The Journal of Immunology.

[22]  W. Debinski,et al.  Mutants of Interleukin 13 with Altered Reactivity toward Interleukin 13 Receptors* , 1999, The Journal of Biological Chemistry.

[23]  E. Silverman,et al.  Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. , 1999, American journal of respiratory and critical care medicine.

[24]  A. Evans,et al.  Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. , 1999, Circulation.

[25]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[26]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[27]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[28]  S. Durham,et al.  Expression of the IL-4 receptor alpha-subunit is increased in bronchial biopsy specimens from atopic and nonatopic asthmatic subjects. , 1998, The Journal of allergy and clinical immunology.

[29]  Christian Fritzsch,et al.  Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany , 1998, The Lancet.

[30]  S. Durham,et al.  IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. , 1997, American journal of respiratory cell and molecular biology.

[31]  J. D. Neely,et al.  Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. , 1994, Science.

[32]  R. de Waal Malefyt,et al.  Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W. Morgan,et al.  The Tucson Children's Respiratory Study. I. Design and implementation of a prospective study of acute and chronic respiratory illness in children. , 1989, American journal of epidemiology.